Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic (Q34080050)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic |
scientific article |
Statements
1 reference
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic (English)
1 reference
Hamid R Hoveyda
1 reference
Eric Marsault
1 reference
René Gagnon
1 reference
Axel P Mathieu
1 reference
Martin Vézina
1 reference
Annick Landry
1 reference
Zhigang Wang
1 reference
Kamel Benakli
1 reference
Sylvie Beaubien
1 reference
Carl Saint-Louis
1 reference
Martin Brassard
1 reference
Jean-François Pinault
1 reference
Luc Ouellet
1 reference
Shridhar Bhat
1 reference
Mahesh Ramaseshan
1 reference
Xiaowen Peng
1 reference
Laurence Foucher
1 reference
Sophie Beauchemin
1 reference
Patrick Bhérer
1 reference
Daniel F Veber
1 reference
Mark L Peterson
1 reference
Graeme L Fraser
1 reference
22 November 2011
1 reference
1 reference
54
1 reference
24
1 reference
8305-8320
1 reference
Identifiers
1 reference
1 reference